Petition · past parliament · Department of Health and Social Care
Fund Cancer Drugs Fund immunotherapy drugs to extend NICE’s 2 year limit
Closed
2,860 signatures
What the petition asks
NICE have approved Cancer Drugs Funding for up 2 years treatment with some immunotherapy drugs as guided by clinical trials. For some patients the drugs result in stable disease to 2 years and may continue for longer. We ask the government to provide funding to extend this beyond 2 years.
My partner has metastatic cancer resistant to standard chemotherapy. In Dec 2017 Merck funded treatment with the immunotherapy drug Pembrolizumab and funding was subsequently approved for up to 2 years through the Cancer Drugs Fund.
My partner responded well, the treatment continued and the cancerous nodes regressed to normal size.
In Dec 2019 the funding and treatment ended. Devastating.
It seems unethical and mentally damaging for cancer patients that funding for such treatments ends when the drug is clearly working. We are therefore asking NICE to extend funding for such patients or to fund further treatment if the disease returns.
My partner responded well, the treatment continued and the cancerous nodes regressed to normal size.
In Dec 2019 the funding and treatment ended. Devastating.
It seems unethical and mentally damaging for cancer patients that funding for such treatments ends when the drug is clearly working. We are therefore asking NICE to extend funding for such patients or to fund further treatment if the disease returns.
Timeline
| 20 Jul 2020 | Petition opened for signatures |
| 20 Jan 2021 | Closed to new signatures |
Key facts
Signatures
2,860
Status
Closed
Department
Department of Health and Social Care
Opened
20 Jul 2020
Closed
20 Jan 2021
Follow this petition
Sign in to get an email when the government responds, a debate is scheduled or held, or the petition closes.
Source: the official petition page. Last checked 15 Jul 2026.